| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-502
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 |
| filingDate |
2009-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6272343fe195d6395c3ab42126d0915
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4eef14cd3824b5dc759e072066fdf86b |
| publicationDate |
2011-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2011046143-A1 |
| titleOfInvention |
Disubstituted phthalazine hedgehog pathway antagonists |
| abstract |
The present invention provides novel 1,4-disubstituted phthalazine hedgehog pathway antagonists useful in the treatment of cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014043608-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9512106-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102863393-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8445493-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8507490-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8273742-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011190304-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102702108-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011178093-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8404687-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010324048-A1 |
| priorityDate |
2008-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |